HuongN. T. T., & QuảngL. V. (2021). Assessment of the toxicities of sorafenib in patients with hepatocelular carcinoma. Tạp Chí Y Dược lâm sàng 108, 17(DB). https://doi.org/10.52389/ydls.v17iDB.1281